<SEC-DOCUMENT>0001193125-26-120230-index.html : 20260323
<SEC-HEADER>0001193125-26-120230.hdr.sgml : 20260323
<ACCEPTANCE-DATETIME>20260323191356
ACCESSION NUMBER:		0001193125-26-120230
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260319
FILED AS OF DATE:		20260323
DATE AS OF CHANGE:		20260323

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Marks Gilbert Lynn
		CENTRAL INDEX KEY:			0001916940
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41331
		FILM NUMBER:		26783812

	MAIL ADDRESS:	
		STREET 1:		821 WASHINGTON ST.
		CITY:			CAPE MAY
		STATE:			NJ
		ZIP:			08204

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AN2 Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001880438
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				820606654
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1300 EL CAMINO REAL, SUITE 100
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		(650) 331-9090

	MAIL ADDRESS:	
		STREET 1:		1300 EL CAMINO REAL, SUITE 100
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>